Evaluation of the efficacy of the dual endothelin 1 receptor antagonist Bosentan in the treatment of Pulmonary Hypertension secondary to Chronic Obstructive Pulmonary Disease and in the treatment of Pulmonary Hypertension secondary to sarcoidosis
Latest Information Update: 09 Dec 2019
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
Most Recent Events
- 09 Dec 2019 New trial record